Rowena Ironside

Angel

Portfolio

companies

Samphire Neuroscience

Medical technology company developing wearable solutions for women's health.

Rowena Ironside

Pre-Seed22 February 2024

$2.3M

Samphire Neuroscience secures $2.3m in pre-seed funding to launch Nettle wearable

The pre-seed round will fund clinical research and regulatory approval for the company's neurostimulation headband.

"Women’s health has been notoriously under-researched and underfunded for decades,"

— Emilė Radytė, CEO and Co-Founder

SOSV + 7 others